Compounding pharmacies make their own versions of weight loss drugs at a fraction of the price but there are some drawbacks.

A new request by Ozempic manufacturer Novo Nordisk could limit the availability of a type of GLP-1—semaglutides—to local ...

Researchers are exploring whether microorganisms found in cow’s milk and soil can help prevent weight gain typically caused ...

According to BMO Capital Markets, Medicare coverage of Lilly’s Zepbound opens the door to using secondary indications to ...

Doctors have long told how they are treating increasing numbers of Brits who end up in hospital after providing false ...

Sales of blockbuster weight-loss drugs have surged in 2024 and are projected to continue rising in the coming years. The ...

So many people are now taking medication that the inexorable rise in obesity could start to reverse, one of the biggest ...

PGC-1α research offers new hope for weight loss by boosting metabolic efficiency and providing accessible management ...

Donald Trump threw out yet another threat of tariffs when he floated hitting Denmark with the economic punishment if it did ...

Putting tariffs on Denmark unless it cedes the island of Greenland could hurt access to a few key products, including popular ...

Novo Nordisk shares fell nearly 30% in the fourth quarter on disappointing clinical trial data, and other concerns. Bank of ...